{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:53:39Z","timestamp":1790798019416,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100021914","name":"Grand Challenges","doi-asserted-by":"publisher","award":["INV-017692"],"award-info":[{"award-number":["INV-017692"]}],"id":[{"id":"10.13039\/100021914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["R01HL141781"],"award-info":[{"award-number":["R01HL141781"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["R01HL128288"],"award-info":[{"award-number":["R01HL128288"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.omtm.2025.101448","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T03:44:40Z","timestamp":1741923880000},"page":"101448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["In vivo HSC transduction in humanized mice mediated by novel capsid-modified HDAd vectors"],"prefix":"10.1016","volume":"33","author":[{"given":"Aphrodite","family":"Georgakopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6742-6266","authenticated-orcid":false,"given":"Andr\u00e9","family":"Lieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101448_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ymthe.2023.10.023","article-title":"Targeted, safe, and efficient gene delivery to human hematopoietic stem and progenitor cells in vivo using the engineered AVID adenovirus vector platform","volume":"32","author":"Yao","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101448_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.omtm.2023.03.008","article-title":"HDAd6\/35++ - A new helper-dependent adenovirus vector platform for in vivo transduction of hematopoietic stem cells","volume":"29","author":"Wang","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101448_bib3","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/bloodadvances.2022007975","article-title":"In vivo HSC transduction in rhesus macaques with an HDAd5\/3+ vector targeting desmoglein 2 and transiently overexpressing cxcr4","volume":"6","author":"Wang","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.omtm.2025.101448_bib4","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139538","article-title":"Curative in vivo hematopoietic stem cell gene therapy of murine thalassemia using large regulatory elements","volume":"5","author":"Wang","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtm.2025.101448_bib5","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ymthe.2020.09.001","article-title":"In Vivo HSC Gene Therapy Using a Bi-modular HDAd5\/35++ Vector Cures Sickle Cell Disease in a Mouse Model","volume":"29","author":"Li","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101448_bib6","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1182\/bloodadvances.2020003702","article-title":"In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal gamma-globin in beta-YAC mice","volume":"5","author":"Li","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.omtm.2025.101448_bib7","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2018-03-838540","article-title":"Reactivation of gamma-globin in adult beta-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing","volume":"131","author":"Li","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101448_bib8","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1172\/JCI122836","article-title":"In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia","volume":"129","author":"Wang","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101448_bib9","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.ymthe.2019.08.006","article-title":"Targeted Integration and High-Level Transgene Expression in AAVS1 Transgenic Mice after In Vivo HSC Transduction with HDAd5\/35++ Vectors","volume":"27","author":"Li","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101448_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.omtm.2018.02.004","article-title":"Integrating HDAd5\/35++ vectors as a new platform of HSC gene therapy of hemoglobinopathies","volume":"9","author":"Li","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101448_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.omtm.2017.11.004","article-title":"A Combined In Vivo HSC Transduction\/Selection Approach Results in Efficient and Stable Gene Expression in Peripheral Blood Cells in Mice","volume":"8","author":"Wang","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101448_bib12","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI200318782","article-title":"Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model","volume":"112","author":"Neff","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101448_bib13","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1172\/JCI40767","article-title":"Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates","volume":"120","author":"Beard","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101448_bib14","doi-asserted-by":"crossref","first-page":"7753","DOI":"10.1038\/s41598-022-11843-z","article-title":"Translational development of a tumor junction opening technology","volume":"12","author":"Kim","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101448_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1365-2249.2001.01458.x","article-title":"Membrane cofactor protein (MCP; CD46) expression in transgenic mice","volume":"124","author":"Kemper","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.omtm.2025.101448_bib16","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1182\/blood-2016-04-711580","article-title":"In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors","volume":"128","author":"Richter","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101448_bib17","first-page":"2085","article-title":"In vivo HSC prime editing rescues sickle cell disease in a mouse model","volume":"141","author":"Li","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101448_bib18","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1182\/bloodadvances.2019000706","article-title":"High-level protein production in erythroid cells derived from in vivo transduced hematopoietic stem cells","volume":"3","author":"Wang","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.omtm.2025.101448_bib19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1158\/0008-5472.CAN-19-1044","article-title":"Prophylactic in vivo hematopoietic stem cell gene therapy with an immune checkpoint inhibitor reverses tumor growth in syngeneic mouse tumor models","volume":"80","author":"Li","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtm.2025.101448_bib20","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1128\/JVI.00205-12","article-title":"A new human DSG2-transgenic mouse model for studying the tropism and pathology of human adenoviruses","volume":"86","author":"Wang","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101448_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"Wang","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2025.101448_bib22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.omtm.2021.12.003","article-title":"Safe and efficient in vivo hematopoietic stem cell transduction in nonhuman primates using HDAd5\/35++ vectors","volume":"24","author":"Li","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101448_bib23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.stem.2014.06.001","article-title":"Kit regulates HSC engraftment across the human-mouse species barrier","volume":"15","author":"Cosgun","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtm.2025.101448_bib24","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1128\/JVI.01825-13","article-title":"Structural and functional studies on the interaction of adenovirus fiber knobs and desmoglein 2","volume":"87","author":"Wang","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101448_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2015.5","article-title":"Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicin","volume":"2","author":"Richter","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101448_bib26","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood-2008-09-178459","article-title":"Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1","volume":"113","author":"Carlisle","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101448_bib27","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.1128\/jvi.71.8.6144-6154.1997","article-title":"Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding","volume":"71","author":"Hsu","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101448_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101343","article-title":"In vitro and in vivo expansion of CD33\/HBG promoter-edited HSPCs with Mylotarg","volume":"32","author":"Georgakopoulou","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101448_bib29","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood.2020010020","article-title":"Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo","volume":"138","author":"Psatha","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101448_bib30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/hgtb.2014.005","article-title":"Superior long-term repopulating capacity of G-CSF+plerixafor-mobilized blood: implications for stem cell gene therapy by studies in the Hbb(th-3) mouse model","volume":"25","author":"Psatha","year":"2014","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2025.101448_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc6659","article-title":"Systemic cancer therapy with engineered adenovirus that evades innate immunity","volume":"12","author":"Atasheva","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2025.101448_bib32","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/14653240902849788","article-title":"Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?","volume":"11","author":"Fitzhugh","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omtm.2025.101448_bib33","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1182\/bloodadvances.2024012757","article-title":"A simplified G-CSF-free procedure allows for in vivo HSC gene therapy of sickle cell disease in a mouse model","volume":"8","author":"Li","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.omtm.2025.101448_bib34","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1182\/bloodadvances.2020003714","article-title":"Single-dose MGTA-145\/plerixafor leads to efficient mobilization and in vivo transduction of HSCs with thalassemia correction in mice","volume":"5","author":"Li","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.omtm.2025.101448_bib35","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/bloodadvances.2023011371","article-title":"Choosing the right mouse model: comparison of humanized NSG and NBSGW mice for in vivo HSC gene therapy","volume":"8","author":"Choo","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.omtm.2025.101448_bib36","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.stemcr.2016.08.005","article-title":"Improved Human Erythropoiesis and Platelet Formation in Humanized NSGW41 Mice","volume":"7","author":"Rahmig","year":"2016","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.omtm.2025.101448_bib37","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood.V81.6.1479.1479","article-title":"Preclinical analysis of cytokine therapy in the SCID-hu mouse","volume":"81","author":"Kyoizumi","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101448_bib38","doi-asserted-by":"crossref","first-page":"10567","DOI":"10.1128\/JVI.01308-08","article-title":"In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46","volume":"82","author":"Wang","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101448_bib39","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ymthe.2003.08.014","article-title":"Improved system for helper-dependent adenoviral vector production","volume":"8","author":"Palmer","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101448_bib40","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ymthe.2004.06.1013","article-title":"Physical and infectious titers of helper-dependent adenoviral vectors: a method of direct comparison to the adenovirus reference material","volume":"10","author":"Palmer","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101448_bib41","doi-asserted-by":"crossref","first-page":"8944","DOI":"10.1128\/jvi.70.12.8944-8960.1996","article-title":"Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo","volume":"70","author":"Lieber","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101448_bib42","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nbt0502-467","article-title":"Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo","volume":"20","author":"Neildez-Nguyen","year":"2002","journal-title":"Nat. Biotechnol."}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125000439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125000439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:02:32Z","timestamp":1786219352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125000439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2329050125000439"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101448","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo HSC transduction in humanized mice mediated by novel capsid-modified HDAd vectors","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101448","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101448"}}